Dr Debbie Shoemark built on our models of the 11 substrates of SARS-CoV-2 Mpro and used software devised by Dr Richard Sessions to design the peptibitor sequences — verified in vitro by @TikaRMalla and others in @SchofieldOxford group to inhibit competitively. 5/n
Thanks to @MarcMoesser, our detailed picture of the essential interactions of SARS-CoV-2 Mpro and its subsites, binding both peptides and small molecules, will help us all to design and refine targeted anti-#Covid_19 therapeutics. 6/n
Computation was central: comparative molecular modelling, molecular dynamics, interactive molecular dynamics in virtual reality, quantum mechanics, computational peptide design, protein-ligand docking, protein-peptide docking, and protein-ligand interaction analysis #CompChem 7/n